Abdulaziz Alfahed

11PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersMedical biochemistry and metabolomics not elsewhere classifiedMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 26, 2026
O-Glycosylation Signatures Shape the Tumour Immune Microenvironment and Associate with Genomic Stability, Drug Resistance Programmes, and Epithelial Differentiation in Colorectal Cancer.

|May 12, 2026
The Colorectal Cancer Glycocode: Tumour Sialylation Is Associated with an Immune-Excluded Phenotype and Distinct Therapeutic Signatures.

|May 12, 2026
Fucosylation Dynamics as a Critical Determinant of Cancer Cell Fate in Colorectal Carcinoma: Integrating Hallmark Plasticity, Microenvironmental Remodelling, and Therapeutic Resistance.

|Jan 27, 2026
Correction: Althenayyan et al. Alternatively Spliced Isoforms of MUC4 and ADAM12 as Biomarkers for Colorectal Cancer Metastasis. J. Pers. Med. 2023, 13, 135.

Saleh Althenayyan, Mohammed H AlMuhanna, Abdulkareem AlAbdulrahman

|Oct 29, 2025
Fusion-Negative NTRK Overexpression Exhibit Biological Relevance in Colorectal Cancer: Implications for Prediction of Responses to Kinase Inhibitors.

Abdulaziz Alfahed

|Jun 27, 2025
PARP Inhibition in Colorectal Cancer-A Comparison of Potential Predictive Biomarkers for Therapy.

Abdulaziz Alfahed

Pageof 2

Frequent Collaborators

7 joint publications

Glowi Alasiri

2 joint publications

Mohammed H AlMuhanna

2 joint publications

Abdulkareem AlAbdulrahman

2 joint publications

Bandar Alghanem